新易盛(300502) - 2019 Q3 - 季度财报
EOPTOLINKEOPTOLINK(SZ:300502)2019-10-28 16:00

Financial Performance - Net profit attributable to shareholders was ¥52,318,192.03, representing a significant increase of 154.34% year-on-year[5]. - Operating revenue for the reporting period was ¥290,905,593.66, up 46.93% compared to the same period last year[5]. - Basic earnings per share increased to ¥0.2229, reflecting a growth of 152.15% year-on-year[5]. - The weighted average return on net assets was 4.38%, an increase from 2.47% in the previous year[5]. - The company reported a net profit excluding non-recurring gains and losses of ¥49,532,702.45, up 154.57% year-on-year[5]. - The company reported a significant increase of 185.25% in taxes payable, totaling ¥19,131,852.48, due to increased profits and corresponding corporate income tax[12]. - The total comprehensive income for Q3 2019 was CNY 52,270,879.55, compared to CNY 20,986,992.81 in Q3 2018, indicating a growth of 149.5%[28]. - The net profit for Q3 2019 was CNY 52,318,192.03, up 154.5% from CNY 20,570,029.31 in Q3 2018[26]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,541,263,316.87, an increase of 11.72% compared to the end of the previous year[5]. - The company’s total liabilities increased by 34.23% in accounts payable, reaching ¥157,430,201.40, due to higher material procurement[12]. - Total liabilities amounted to CNY 295,968,968.65, up from CNY 243,757,264.24, indicating a growth of around 21.5%[12]. - Current liabilities increased to CNY 289,315,528.34 from CNY 238,021,225.71, which is an increase of about 21.5%[19]. - The company's equity attributable to shareholders reached CNY 1,245,294,348.22, compared to CNY 1,135,777,463.54, showing an increase of about 9.7%[20]. Cash Flow - Cash flow from operating activities showed a decline of 69.65% year-to-date, totaling ¥91,695,388.32[5]. - The company reported a 69.65% decrease in net cash flow from operating activities, totaling ¥91,695,388.32, primarily due to increased cash payments for goods and employee compensation[12]. - Cash flow from operating activities generated ¥91,695,388.32, up from ¥302,122,578.11 in the prior period[39]. - The net cash flow from operating activities was ¥88,677,717.53, a decrease of 67.9% compared to ¥275,965,984.20 in the previous year[42]. - The total cash and cash equivalents at the end of the period reached ¥228,964,069.54, up from ¥179,844,420.53 at the end of the previous year, reflecting a net increase of ¥62,456,317.76[43]. Research and Development - Research and development expenses rose by 31.66% to ¥55,192,325.30, reflecting the company's commitment to enhancing R&D investments[12]. - Research and development expenses rose to CNY 23,723,884.88, a significant increase of 78.2% from CNY 13,307,034.21 in the previous year[25]. - R&D expenses increased to ¥41,847,782.61 from ¥33,735,115.18, representing a growth of approximately 24.5%[35]. Market Strategy - The company plans to continue its market expansion and product development strategies to sustain growth in the upcoming quarters[8]. - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[34]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 20,720, with the top ten shareholders holding significant stakes[7]. - The company executed a stock repurchase plan, canceling 1,813,350 restricted shares due to unmet vesting conditions[13].

EOPTOLINK-新易盛(300502) - 2019 Q3 - 季度财报 - Reportify